Hancai Dan

601 total citations
13 papers, 182 citations indexed

About

Hancai Dan is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hancai Dan has authored 13 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hancai Dan's work include Lung Cancer Treatments and Mutations (5 papers), Cancer-related Molecular Pathways (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Hancai Dan is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Cancer-related Molecular Pathways (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Hancai Dan collaborates with scholars based in United States, China and Hong Kong. Hancai Dan's co-authors include Jipei Liao, Zejia Yang, Kevin J. Cullen, Rena G. Lapidus, Brandon Carter‐Cooper, Xin‐Yuan Guan, Xinghuan Wang, Gang Wang, Guofeng Qian and Rui Cao and has published in prestigious journals such as British Journal of Cancer, Oncotarget and BMC Cancer.

In The Last Decade

Hancai Dan

13 papers receiving 182 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hancai Dan United States 8 115 54 47 30 27 13 182
Yanrong Hao China 10 121 1.1× 93 1.7× 40 0.9× 44 1.5× 12 0.4× 35 291
Maria D’Apolito Italy 7 119 1.0× 62 1.1× 68 1.4× 35 1.2× 15 0.6× 16 235
Rutao Cui China 10 191 1.7× 81 1.5× 43 0.9× 35 1.2× 24 0.9× 15 337
Yongyan Dang China 5 143 1.2× 59 1.1× 42 0.9× 18 0.6× 22 0.8× 6 207
F Bonanni Italy 6 104 0.9× 33 0.6× 14 0.3× 15 0.5× 35 1.3× 15 184
Yingzhi Qin China 13 270 2.3× 43 0.8× 216 4.6× 77 2.6× 9 0.3× 34 413
Zhen Shen China 9 162 1.4× 60 1.1× 94 2.0× 33 1.1× 4 0.1× 27 264
Chrysovalantou Mihailidou Greece 9 156 1.4× 46 0.9× 76 1.6× 30 1.0× 7 0.3× 12 284

Countries citing papers authored by Hancai Dan

Since Specialization
Citations

This map shows the geographic impact of Hancai Dan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hancai Dan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hancai Dan more than expected).

Fields of papers citing papers by Hancai Dan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hancai Dan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hancai Dan. The network helps show where Hancai Dan may publish in the future.

Co-authorship network of co-authors of Hancai Dan

This figure shows the co-authorship network connecting the top 25 collaborators of Hancai Dan. A scholar is included among the top collaborators of Hancai Dan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hancai Dan. Hancai Dan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Yang, Zejia, Xiaoxuan Fan, Yong Teng, et al.. (2025). Evaluation of co‑inhibition of ErbB family kinases and PI3K for HPV‑negative head and neck squamous cell carcinoma. Oncology Reports. 53(3). 2 indexed citations
2.
3.
Lang, Liwei, Fanghui Chen, Yamin Li, et al.. (2023). Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer. Cancer Research Communications. 3(4). 659–671. 10 indexed citations
4.
Yang, Zejia, Jipei Liao, Lisa M. Schumaker, et al.. (2022). Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma. Oral Oncology. 131. 105939–105939. 8 indexed citations
5.
Yang, Zejia, Jipei Liao, Rena G. Lapidus, et al.. (2022). Targeting Wee1 kinase to suppress proliferation and survival of cisplatin-resistant head and neck squamous cell carcinoma. Cancer Chemotherapy and Pharmacology. 89(4). 469–478. 4 indexed citations
6.
Wang, Linbo, Mohammad A. Khan, Wei Guang, et al.. (2022). Co-Targeting ErbB Receptors and the PI3K/AKT Axis in Androgen-Independent Taxane-Sensitive and Taxane-Resistant Human Prostate Cancer Cells. Cancers. 14(19). 4626–4626. 2 indexed citations
7.
Liao, Jipei, Zejia Yang, Brandon Carter‐Cooper, et al.. (2020). Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition. Clinical & Experimental Metastasis. 37(2). 283–292. 15 indexed citations
8.
Yang, Zejia, Jipei Liao, Kevin J. Cullen, & Hancai Dan. (2020). Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma. Cell Death Discovery. 6(1). 36–36. 11 indexed citations
9.
Lin, Xiaofeng, et al.. (2020). Concurrent inhibition of ErbB family and MEK/ERK kinases to suppress non-small cell lung cancer proliferation.. PubMed. 12(3). 847–856. 5 indexed citations
10.
Yang, Zejia, Jipei Liao, Brandon Carter‐Cooper, et al.. (2019). Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway. BMC Cancer. 19(1). 485–485. 32 indexed citations
11.
Lin, Xiaofeng, Jipei Liao, Zejia Yang, et al.. (2019). Inhibition of cisplatin-resistant head and neck squamous cell carcinoma by combination of Afatinib with PD0325901, a MEK inhibitor.. PubMed. 9(6). 1282–1292. 16 indexed citations
12.
Li, Zhipeng, Jipei Liao, Zejia Yang, et al.. (2018). Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer. British Journal of Cancer. 120(3). 306–316. 13 indexed citations
13.
Cao, Rui, Zhe Meng, Tongzu Liu, et al.. (2016). DecreasedTRPM7inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway. Oncotarget. 7(45). 72941–72960. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanrong Hao Breakdown of academic impact, for papers by Maria D’Apolito Breakdown of academic impact, for papers by Rutao Cui Breakdown of academic impact, for papers by Yongyan Dang Breakdown of academic impact, for papers by F Bonanni Breakdown of academic impact, for papers by Yingzhi Qin Breakdown of academic impact, for papers by Zhen Shen Breakdown of academic impact, for papers by Chrysovalantou Mihailidou
Rankless by CCL
2026